Showing results (291-300 of 319) with videos related to
Sort By:
Pageof 32
Neurology|February 27, 2008
Neuropathology of primary adult-onset dystoniaJ L Holton, S A Schneider, T Ganesharajah, et al.Annals of Neurology|February 1, 1992
Striatal D2 receptor status in patients with Parkinson's disease, striatonigral degeneration, and progressive supranuclear palsy, measured with 11C-raclopride and positron emission tomographyD J Brooks, V Ibanez, G V Sawle, et al.Annals of Neurology|January 1, 1994
Indices of oxidative stress and mitochondrial function in individuals with incidental Lewy body diseaseD T Dexter, J Sian, S Rose, et al.Annals of Neurology|February 1, 1997
Dopaminergic function in familial Parkinson's disease: a clinical and 18F-dopa positron emission tomography studyP Piccini, P K Morrish, N Turjanski, et al.Brain : a Journal of Neurology|April 19, 2002
Pathological, clinical and genetic heterogeneity in progressive supranuclear palsyH R Morris, G Gibb, R Katzenschlager, et al.Neurology|July 14, 2004
Anti-basal ganglia antibodies in patients with atypical dystonia and tics: a prospective studyM J Edwards, E Trikouli, D Martino, et al.Journal of Neurology, Neurosurgery, and Psychiatry|February 28, 2002
Sequence analysis of tau in familial and sporadic progressive supranuclear palsyH R Morris, R Katzenschlager, J C Janssen, et al.Brain : a Journal of Neurology|April 29, 1998
A study of medial pallidotomy for Parkinson's disease: clinical outcome, MRI location and complicationsM Samuel, E Caputo, D J Brooks, et al.Human Molecular Genetics|July 8, 2005
The H1c haplotype at the MAPT locus is associated with Alzheimer's diseaseA J Myers, M Kaleem, L Marlowe, et al.Journal of Neurology, Neurosurgery, and Psychiatry|March 12, 2009
Olfaction in patients with suspected parkinsonism and scans without evidence of dopaminergic deficit (SWEDDs)L Silveira-Moriyama, P Schwingenschuh, A O'Donnell, et al.Pageof 32